Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy

• Status: Completed
• Trial end date: 2021-10-30
• Target enrollment: 0
• Participant gender: All

Summary

This study is a randomized, double-blind parallel group placebo-controlled clinical trial with the aim of investigating the effect of probiotic versus placebo on drug-resistant adult patients with epilepsy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mazandaran University of Medical Sciences

Criteria

Inclusion Criteria:

Drug resistant epilepsy

Exclusion Criteria:

• Hypersensitivity to probiotic

• Acute pancreatitis

• Pregnancy

• Breastfeeding

• Being under treatment with corticosteroids

• Being under treatment with antibiotics during 2 months before enrollment

• Need for antibiotic therapy during the study

• Change in anti-seizure medication within the month before enrollment